Evidence map›Paper›PMID 38529346›Full record

ArticleERJ open research2024

ERS International Congress 2023: highlights from the Airway Diseases Assembly.

Laura Bergantini, James Baker, Apostolos Bossios, Gert-Jan Braunstahl, Lennart H Conemans, Francesco Lombardi, Alexander G Mathioudakis, Pavol Pobeha, Fabio Luigi Massimo Ricciardolo, Leidy Paola Prada Romero and 5 more

Abstract read
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Laura BergantiniRespiratory Disease Unit, Department of Medical Sciences, Surgery, and Neurosciences, University of Siena, Siena, Italy.
James BakerDivision of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-0301-2002
Apostolos BossiosKarolinska Severe Asthma Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-0494-2690
Gert-Jan BraunstahlFranciscus Gasthuis and Vlietland Hospital, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7671-3742
Lennart H ConemansMaastricht Universitair Medisch Centrum+, Maastricht, The Netherlands.
Francesco LombardiFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0003-2254-5119
Alexander G MathioudakisDivision of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-4675-9616
Pavol PobehaFaculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
Fabio Luigi Massimo RicciardoloDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.ORCID https://orcid.org/0000-0003-1826-5018
Leidy Paola Prada RomeroNeumóloga en Fundación Neumológica Colombiana Bogotá, Bogotá, Colombia.
Florence SchleichRespiratory Medicine, CHU Sart-Tilman B35, University of Liège, GIGA I3, Liège, Belgium.ORCID https://orcid.org/0000-0002-2678-1373
Robert J SnelgroveNational Heart and Lung Institute, Imperial College London, London, UK.
Frederik TrinkmannDepartment of Pneumology and Critical Care Medicine, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.ORCID https://orcid.org/0000-0001-5877-877X
Lena UllerDepartment of Experimental Medical Science, Unit of Respiratory Immunopharmacology, Lund University, Lund, Sweden.
Augusta BeechDivision of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-2690-5364

Funding

Wellcome Trust
6 · The paper itself

Abstract

In this review, early career and senior members of Assembly 5 (Airway Diseases, Asthma, COPD and Chronic Cough) present key recent findings pertinent to airway diseases that were presented during the European Respiratory Society International Congress 2023 in Milan, Italy, with a particular focus on asthma, COPD, chronic cough and bronchiectasis. During the congress, an increased number of symposia, workshops and abstract presentations were organised. In total, 739 abstracts were submitted for Assembly 5 and the majority of these were presented by early career members. These data highlight the increased interest in this group of respiratory diseases.

Identifiers

PMID38529346
PMCPMC10962455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.